Mapfre SA
MAD:MAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mapfre SA
MAD:MAP
|
ES |
|
G
|
G Capital PCL
SET:GCAP
|
TH |
|
P
|
Pure Hydrogen Corporation Ltd
ASX:PH2
|
US |
|
B
|
Bottomline Technologies Inc
F:BOT
|
US |
|
Thales SA
PAR:HO
|
FR |
|
Dorel Industries Inc
F:DO4C
|
CA |
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
IN |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
Floridienne SA
F:OI9
|
BE |
|
H
|
Hor Kew Corporation Ltd
SGX:BBP
|
SG |
|
scPharmaceuticals Inc
NASDAQ:SCPH
|
US |
Wall Street
Price Targets
MAP Price Targets Summary
Mapfre SA
According to Wall Street analysts, the average 1-year price target for
MAP
is 3.932 EUR
with a low forecast of 2.656 EUR and a high forecast of 4.515 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MAP's stock price target?
Price Target
3.932
EUR
According to Wall Street analysts, the average 1-year price target for
MAP
is 3.932 EUR
with a low forecast of 2.656 EUR and a high forecast of 4.515 EUR.
What is Mapfre SA's Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Mapfre SA's revenue is
1%.
The projected
CAGR
for the next 3 years is
13%.
What is Mapfre SA's Net Income forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Mapfre SA's net income is
1%.
The projected
CAGR
for the next 3 years is
5%.
